| Biotechnology Industry | Healthcare Sector | Mr. Timothy Owen Grogan B.Sc., LLB CEO | SET Exchange | - ISIN |
| Australia Country | - Employees | - Last Dividend | - Last Split | - IPO Date |
Bio-Gene Technology Limited is an innovative agtech development company headquartered in Melbourne, Australia, dedicated to the advancement and commercialization of novel insecticides and pesticides. Since its inception in 1995, Bio-Gene Technology has been at the forefront of creating effective solutions for animal health, crop protection, public health, and consumer applications. Through strategic research collaboration agreements with prestigious institutions like James Cook University, BASF, the Grains Research and Development Corporation, and the Queensland Department of Agriculture and Fisheries, Bio-Gene is committed to refining and testing its pioneering products, ensuring they meet the highest standards of safety and efficacy.
Flavocide is a synthetically produced, nature-identical compound pioneered by Bio-Gene Technology. This flagship product is designed to provide a novel mode of action for the control of insect pests across a range of applications, including crop protection and public health. The development and testing of Flavocide, conducted in collaboration with industry leaders and research institutions, underscore its potential as a safe, effective, and environmentally friendly insecticide.
Qcide is a natural oil derived from a specially cultivated strain of the eucalyptus cloeziana tree. This product represents Bio-Gene Technology’s commitment to leveraging nature's bounty to create sustainable, chemical-free alternatives to traditional pesticides. Through a research collaboration with James Cook University, Bio-Gene is refining the extraction process to ensure the highest quality and efficacy of Qcide, making it suitable for a variety of applications, including consumer products and crop protection.